In addition to determining the virus-specific humoral immune response, we performed, to our knowledge, the first in-depth characterization of SARS-CoV-2-specific CD8+ T cell immunity at the epitope level in COVID-19 convalescent and mRNA-vaccinated MM patients. This evidence concerns the gene CD8A and COVID-19.